V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330007903 | 330004705 | 1.72 | null | Curative (C) | 2015-01-14 | 2015-02-04 | VAI (Ifos 3g/m2) | Y | null | 330013125 | VAI |
| 330007904 | 330004707 | 1.72 | 110.3 | Curative (C) | 2014-03-14 | 2014-03-14 | CARBOPLATIN + RT | N | N | 330013135 | CARBOPLATIN + RT |
| 330007905 | 330010643 | 1.9 | 72.8 | Curative (C) | 2013-02-01 | 2013-02-01 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330013135 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007906 | 330012452 | null | 67 | Curative (C) | 2015-03-17 | 2015-04-21 | BENDAMUSTINE + RITUXIMAB | N | N | 330013136 | BENDAMUSTINE + RITUXIMAB |
| 330007907 | 330004708 | 1.6 | null | Palliative (P) | 2015-04-16 | 2015-04-16 | Paclitaxel 7 day | 02 | N | 330013142 | PACLITAXEL |
| 330007908 | 330008568 | 1.86 | null | null | 2015-05-10 | 2016-03-25 | Cetuximab + Radiotherapy Maint | N | N | 330013145 | CETUXIMAB + RT |
| 330007909 | 330008568 | 1.69 | 62 | Curative (C) | 2016-10-31 | 2016-11-30 | CARBOPLATIN + RT | 2 | null | 330013145 | CARBOPLATIN + RT |
| 330007910 | 330011802 | 1.75 | 85.4 | Neo-adjuvant (N) | 2017-02-28 | 2017-03-19 | Cetuximab + Radiotherapy Load | 02 | N | 330013154 | CETUXIMAB + RT |
| 330007911 | 330004713 | 0 | 61.7 | Neo-adjuvant (N) | 2016-06-27 | 2017-04-13 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330013155 | CARBO + FLUOROURACIL |
| 330007912 | 330004713 | null | 46.9 | Neo-adjuvant (N) | 2014-06-23 | 2014-06-23 | Carboplatin + Etoposide iv&po | null | null | 330013155 | CARBOPLATIN + ETOPOSIDE |
| 330007915 | 330004717 | 1.72 | 58.9 | Disease modification (D) | 2015-07-28 | 2015-07-29 | VAI (Ifos 3g/m2) | Y | N | 330013164 | VAI |
| 330007916 | 330008571 | null | 0 | Curative (C) | 2016-04-03 | 2016-08-30 | VAI (Ifos 3g/m2) | 02 | null | 330013170 | VAI |
| 330007917 | 330004719 | 1.8 | 59.2 | Curative (C) | 2016-08-08 | 2016-11-07 | ALL UKALL2011 Maintenance A3 | N | N | 330013173 | UKALL2011 |
| 330007918 | 330004721 | null | 84.2 | Disease modification (D) | 2014-07-14 | 2014-11-02 | ALL UKALL2011 Cap Int Maint C PAsp | 02 | N | 330013174 | UKALL2011 |
| 330007919 | 330004723 | 1.61 | 59 | Curative (C) | 2015-12-10 | 2015-12-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330013182 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007920 | 330004724 | null | 64.5 | Neo-adjuvant (N) | null | 2015-02-16 | Cisplatin + Docetaxel +Fluorouracil | null | null | 330013187 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007921 | 330004724 | 1.74 | 90.05 | Neo-adjuvant (N) | 2018-06-29 | 2018-07-03 | Carboplatin + Etoposide iv&po | N | N | 330013187 | CARBOPLATIN + ETOPOSIDE |
| 330007922 | 330004724 | 1.7 | null | Palliative (P) | 2015-02-13 | 2015-02-21 | Cetuximab + Radiotherapy Maint | N | N | 330013187 | CETUXIMAB + RT |
| 330007923 | 330004724 | 1.72 | 50.7 | Curative (C) | 2014-02-17 | 2014-02-17 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 330013187 | PACLITAXEL |
| 330007924 | 330013293 | 1.63 | 69 | Curative (C) | 2017-04-30 | 2017-04-30 | CARBOPLATIN + ETOPOSIDE | N | Y | 330013204 | CARBOPLATIN + ETOPOSIDE |
| 330007925 | 330004725 | 1.79 | 19.9 | Curative (C) | 2015-01-23 | 2015-02-24 | Carboplatin + Etoposide IV 3 day | N | N | 330013206 | CARBOPLATIN + ETOPOSIDE |
| 330007926 | 330004726 | 0 | null | Palliative (P) | 2014-06-09 | 2014-06-13 | Carboplatin + Etoposide IV 3 day | N | N | 330013211 | CARBOPLATIN + ETOPOSIDE |
| 330007927 | 330004726 | 1.78 | 93.1 | null | 2017-11-20 | 2017-11-22 | Cetuximab + Radiotherapy Maint | N | N | 330013211 | CETUXIMAB + RT |
| 330007928 | 330004727 | 1.72 | null | Neo-adjuvant (N) | 2017-11-23 | 2017-11-23 | CETUXIMAB + RT | N | N | 330013216 | CETUXIMAB + RT |
| 330007929 | 330004728 | null | 48.35 | Palliative (P) | null | 2017-03-03 | Carboplatin + Etoposide iv&po | null | null | 330013222 | CARBOPLATIN + ETOPOSIDE |
| 330007930 | 330004729 | 1.76 | 77.8 | Neo-adjuvant (N) | 2013-11-30 | 2013-12-10 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330013223 | CARBO + FLUOROURACIL |
| 330007931 | 330008576 | 1.55 | 60.9 | Palliative (P) | 2015-07-09 | 2015-07-09 | PACLITAXEL | 2 | N | 330013229 | PACLITAXEL |
| 330007932 | 330008576 | 0 | 32 | null | null | 2014-08-18 | CARBOPLATIN + RT | N | N | 330013229 | CARBOPLATIN + RT |
| 330007933 | 330008576 | null | 66.3 | Curative (C) | 2014-12-31 | 2014-12-31 | Bendamustine+Rituximab(Sub Courses) | 02 | null | 330013229 | BENDAMUSTINE + RITUXIMAB |
| 330007934 | 330008578 | 1.78 | 64.5 | Palliative (P) | 2014-10-02 | 2014-10-03 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330013241 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007935 | 330008578 | 1.63 | 61.9 | Curative (C) | 2013-10-17 | 2013-11-07 | ALL UKALL2011 (ProtM-A) C PegAsp | 2 | null | 330013241 | UKALL2011 |
| 330007936 | 330008579 | 1.76 | null | Neo-adjuvant (N) | 2013-11-21 | 2013-11-22 | CARBOPLATIN + RT | N | N | 330013243 | CARBOPLATIN + RT |
| 330007937 | 330004734 | 1.67 | 64.4 | Curative (C) | 2013-05-12 | 2013-05-25 | CARBOPLATIN + RT | N | N | 330013245 | CARBOPLATIN + RT |
| 330007938 | 330004735 | 1.77 | 58.5 | Palliative (P) | 2017-12-16 | 2017-12-17 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 330013247 | PACLITAXEL |
| 330007939 | 330004740 | 0 | 61 | Disease modification (D) | 2013-04-23 | 2013-05-14 | ALL UKALL2011 IndB Std Dex (PegAsp) | 01 | N | 330013250 | UKALL2011 |
| 330007940 | 330008581 | 1.8 | null | Palliative (P) | 2017-10-24 | 2018-01-15 | Carboplatin + Etoposide iv&po | 02 | N | 330013250 | CARBOPLATIN + ETOPOSIDE |
| 330007941 | 330008581 | 1.61 | 66.8 | Palliative (P) | 2015-07-26 | 2015-07-29 | Paclitaxel (2 or 3 weekly) | 02 | N | 330013250 | PACLITAXEL |
| 330007942 | 330008581 | null | 80.2 | Neo-adjuvant (N) | 2017-02-11 | 2017-03-03 | BENDAMUSTINE + RITUXIMAB | 02 | null | 330013250 | BENDAMUSTINE + RITUXIMAB |
| 330007943 | 330004743 | 1.74 | 68.8 | Neo-adjuvant (N) | 2017-10-11 | 2017-11-21 | CARBOPLATIN + ETOPOSIDE | 02 | null | 330013263 | CARBOPLATIN + ETOPOSIDE |
| 330007944 | 330004744 | null | 87.6 | Curative (C) | 2017-12-14 | 2017-12-17 | CARBOPLATIN + ETOPOSIDE | N | Y | 330013267 | CARBOPLATIN + ETOPOSIDE |
| 330007945 | 330004745 | 1.8 | 59 | Palliative (P) | 2016-06-14 | 2016-06-16 | VAI (Ifos 3g/m2) | N | Y | 330013272 | VAI |
| 330007946 | 330004746 | 1.53 | 51.2 | Adjuvant (A) | null | 2016-12-16 | VAI (Ifos 3g/m2) | null | null | 330013273 | VAI |
| 330007947 | 330008583 | null | null | Disease modification (D) | 2015-11-28 | 2015-11-28 | Bendamustine+Rituximab(Sub Courses) | 2 | null | 330013274 | BENDAMUSTINE + RITUXIMAB |
| 330007948 | 330004748 | 1.58 | 71 | Curative (C) | 2014-01-28 | 2014-02-11 | Cetuximab + Radiotherapy Load | N | N | 330013276 | CETUXIMAB + RT |
| 330007951 | 330004750 | 1.7 | 54.6 | Palliative (P) | 2015-07-10 | 2015-07-26 | CARBOPLATIN + PACLITAXEL | N | N | 330013281 | CARBOPLATIN + PACLITAXEL |
| 330007952 | 330004753 | 1.75 | 88.6 | Neo-adjuvant (N) | 2017-05-15 | 2017-05-21 | Carboplatin + Etoposide IV 3 day | 01 | N | 330013282 | CARBOPLATIN + ETOPOSIDE |
| 330007953 | 330008586 | 1.7 | 123.9 | Neo-adjuvant (N) | 2013-05-10 | 2013-05-10 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330013284 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007954 | 330004755 | 1.57 | 8.6 | Palliative (P) | null | 2014-08-19 | VAI (Ifos 3g/m2) | N | N | 330013286 | VAI |
| 330007955 | 330004756 | null | 94.3 | Neo-adjuvant (N) | 2015-04-04 | 2015-10-07 | Paclitaxel (2 or 3 weekly) | N | null | 330013286 | PACLITAXEL |
| 330007956 | 330004756 | null | 32 | Palliative (P) | 2017-04-23 | 2017-06-23 | Paclitaxel 7 day | N | N | 330013286 | PACLITAXEL |